Regenerative Medicine Market
According to the latest report by IMARC Group, titled “Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on regenerative medicine industry report. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global regenerative medicine market reached a value of US$ 14.78 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 50.44 Billion by 2027, exhibiting at a CAGR of 22.6% during 2022-2027.
Regenerative medicine helps to repair and replace damaged organs and tissue. It is used to treat chronic diseases and disorders, such as Alzheimer’s, diabetes, and others. It is an interdisciplinary field that uses engineering and life science principles to stimulate regeneration in damaged or wounded organs and tissues. It challenges current healthcare practices by targeting the treatment of the root causes of disease and disorders. Moreover, numerous market players are introducing several technologies for developing stem cell therapies to increase the efficiency of stem cell research and commercial applications, which, in turn, is driving the product demand.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/regenerative-medicine-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Global Regenerative Medicine Market Trends:
The global market is majorly driven by the increasing prevalence of diseases, such as congestive heart failure, myocardial infarction, Parkinson’s disease, varied forms of bone loss, and Duchenne muscular dystrophy (DMD). In line with this, the rising demand for cell therapy is positively influencing the market for regenerative medicine. Furthermore, bladder, ureter, and urethra reconstruction has been conventionally dependent on heterotopic autologous grafts, such as intestine, colon, or stomach, thus catalyzing the market growth. Besides this, the growing consolidation among healthcare juggernauts is creating a positive outlook for the market. Additionally, the accelerating number of clinical trials for regenerative therapies is providing a boost to the market.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/regenerative-medicine-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Allergan PLC (AbbVie Inc.)
- Amgen Inc.
- Baxter International Inc.
- BD (Becton, Dickinson and Company)
- Integra Lifesciences Holdings Corporation
- Medtronic plc
- Mimedx Group Inc.
- Novartis AG
- Osiris Therapeutics Inc. (Smith & Nephew plc)
- Thermo Fisher Scientific Inc
Regenerative Medicine Market Segmentation:
Our report has categorized the market based on region, type, application and end user.
Breakup by Type:
- Stem Cell Therapy
- Biomaterial
- Tissue Engineering
- Others
Breakup by Application:
- Bone Graft Substitutes
- Osteoarticular Diseases
- Dermatology
- Cardiovascular
- Central Nervous System
- Others
Breakup by End User:
- Hospitals
- Specialty Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
